High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

(2022) et al.   Scientific Data

Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis

(2021) Asma Boumaza et al.   JOURNAL OF INFECTIOUS DISEASES

Dysregulated transcriptional responses to SARS-CoV-2 in the periphery

(2021) Micah T. McClain et al.   Nature Communications

A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood

(2021) Dianna L. Ng et al.   Science Advances

Profound dysregulation of T cell homeostasisand function in patients with severe COVID‐19

(2021) Sarah Adamo et al.   ALLERGY

Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2

(2021) Yi‐Hao Chan et al.   EMBO Molecular Medicine

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

(2021) Toni M. Delorey et al.   NATURE

Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19

(2021) Andreas Barratt-Due et al.   ANNALS OF INTERNAL MEDICINE

Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory

(2021) Andreas Lind et al.   JOURNAL OF CLINICAL VIROLOGY

Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2

(2021) Chia-Ming Su et al.   Scientific Reports

Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome

(2021) Imran Sulaiman et al.   Nature Microbiology

No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway

(2021) Lamprini Veneti et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome

(2021) Kiran Iqbal Masood et al.   Scientific Reports

Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9

(2021) Tøri Vigeland Lerum et al.   Scientific Reports

Effect of SARS-CoV-2 proteins on vascular permeability

(2021) Rossana Rauti et al.   eLife

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

(2020) Evangelos J. Giamarellos-Bourboulis et al.   Cell Host & Microbe

Clinical and immunological features of severe and moderate coronavirus disease 2019

(2020) Guang Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Bo Diao et al.   Frontiers in Immunology

Longitudinal analyses reveal immunological misfiring in severe COVID-19

(2020) Carolina Lucas et al.   NATURE

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

(2020) Jérôme Hadjadj et al.   SCIENCE

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

(2020) Carolyn Rydyznski Moderbacher et al.   CELL

SARS‐CoV‐2 specific virulence factors in COVID‐19

(2020) Ashutosh Kumar et al.   JOURNAL OF MEDICAL VIROLOGY

An inflammatory cytokine signature predicts COVID-19 severity and survival

(2020) Diane Marie Del Valle et al.   NATURE MEDICINE

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

(2020) Prabhu S. Arunachalam et al.   SCIENCE

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway

(2020) Jin-Yan Li et al.   VIRUS RESEARCH

Two distinct immunopathological profiles in autopsy lungs of COVID-19

(2020) Ronny Nienhold et al.   Nature Communications

SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant

(2020) Yoriyuki Konno et al.   Cell Reports

Large-Scale Multi-omic Analysis of COVID-19 Severity

(2020) Katherine A. Overmyer et al.   Cell Systems

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection

(2020) Niyati Desai et al.   Nature Communications

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections

(2020) Simone A. Thair et al.   iScience

CCL21 as a potential serum biomarker for pulmonary arterial hypertension in Systemic Sclerosis

(2018) Anna-Maria Hoffmann-Vold et al.   Arthritis & Rheumatology

Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components

(2017) Dustin R. Glasner et al.   PLoS Pathogens

The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis

(2016) Dustin R. Glasner et al.   Annual Review of Virology

Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells

(2014) Bente Halvorsen et al.   CARDIOVASCULAR RESEARCH

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo

(2013) A. Heine et al.   BLOOD

Characterization of CCL19 and CCL21 in rheumatoid arthritis

(2011) Sarah R. Pickens et al.   ARTHRITIS AND RHEUMATISM

CCR 7 Ligands Are Required for Development of Experimental Autoimmune Encephalomyelitis through Generating IL-23-Dependent Th17 Cells

(2009) T. Kuwabara et al.   JOURNAL OF IMMUNOLOGY

Jak3 Is Involved in Dendritic Cell Maturation and CCR7-Dependent Migration

(2009) Ana Rivas-Caicedo et al.   PLoS One